ClinicalTrials.gg
CompletedNCT01501006SBIUpdated Mar 20, 2018

Social and Behavioral Influence (SBI)

An observational study in Communication, sponsored by University of Rochester. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2018-03-20.

Sponsored by University of Rochester · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
96
Sex
All
01

Study summary

The purpose of the study is to improve patient-physician communication and clinical decisions in the context of serious illness that may affect important clinical outcomes. The investigators will examine how variations in communication patterns and clinical decisions are affected by patient demographics (e.g age, sex), patient interactional style (e.g. communication behaviors) and physician characteristics (e.g. attitudes, background, training).

Read the detailed description

This will be a randomized field experiment. Physicians will receive two unannounced covert standardized patient (SP) visits during the 12-24 months after enrollment. SPs are trained actors who will pose as patients to assess physician behavior and communication. Each SP will present just like a real patient, and will have a standardized fabricated scenario and identity. The SP visit will be unannounced; the physician will not be informed at the time of the visit that they are seeing an SP. The visits will be covertly audio-recorded. This is being conducted at 3 sites: University of Rochester, Rochester, NY; Purdue, IN; and University of Michigan.

02

Conditions studied

  • Communication

Browse trials for

Keywords

  • Physicians
03

In context

Communication

198 studies on the registry are indexed under Communication; 85 are open to participants now.

This study's enrollment of 96 is close to the median of 100 across 27 observational studies indexed under Communication.

Browse Communication studies →

Lead sponsor

University of Rochester is the lead sponsor of 728 studies on the registry; 115 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Male and Female physicians of all races and ethnicities

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently in clinical practice
  • Do not plan on moving during the next year

Exclusion criteria

Exclusion Criteria:

  • Non-physicians
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
96 participants (actual)
Patient registry
No

Groups and cohorts

  • Patient Roles

    Physician communication styles will be evaluated with different patient roles.

06

What researchers measure

Primary outcomes

  1. Physicians Communication Style

    To examine the degree to which physicians communication style (ex inclusive, authoritative) and clinical decisions (ex. aggressive,passive) differ according to patient characteristics. Unit of Measure: Audio recordings of office visits, will be transcribed, deidentified, and coded.

    Time frame: 2 years

Secondary outcomes

  1. Physician Communication Moderators (Sex,Class)

    To examine how patients participating in their care reduces these patient-specific differences in physician communication behaviors and decisions. Unit of Measure: Audio recordings of office visits, will be transcribed, deidentified, and coded.

    Time frame: 2 years

07

Study locations

1 site
  • University Of Rochester
    Rochester, New York 14642, United States
08

References and documents

Publications

  • Shields CG, Griggs JJ, Fiscella K, Elias CM, Christ SL, Colbert J, Henry SG, Hoh BG, Hunte HER, Marshall M, Mohile SG, Plumb S, Tejani MA, Venuti A, Epstein RM. The Influence of Patient Race and Activation on Pain Management in Advanced Lung Cancer: a Randomized Field Experiment. J Gen Intern Med. 2019 Mar;34(3):435-442. doi: 10.1007/s11606-018-4785-z. Epub 2019 Jan 10. PubMed 30632104 ↗
  • Elias CM, Shields CG, Griggs JJ, Fiscella K, Christ SL, Colbert J, Henry SG, Hoh BG, Hunte HER, Marshall M, Mohile SG, Plumb S, Tejani MA, Venuti A, Epstein RM. The social and behavioral influences (SBI) study: study design and rationale for studying the effects of race and activation on cancer pain management. BMC Cancer. 2017 Aug 25;17(1):575. doi: 10.1186/s12885-017-3564-2. PubMed 28841847 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01501006
Responsible party
Ronald Epstein (Principal Investigator, University of Rochester) — Principal investigator
First posted
Dec 29, 2011
Start date
Oct 2010
Primary completion
Mar 2017
Completion
Mar 2017
Last update
Mar 20, 2018

Study contacts

Ronald Epstein, MD
principal investigator · University of Rochester

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion